[go: up one dir, main page]

DK0941221T3 - Substituerede dihydrobenzofuraner som PDE-inhibitorer - Google Patents

Substituerede dihydrobenzofuraner som PDE-inhibitorer

Info

Publication number
DK0941221T3
DK0941221T3 DK97950157T DK97950157T DK0941221T3 DK 0941221 T3 DK0941221 T3 DK 0941221T3 DK 97950157 T DK97950157 T DK 97950157T DK 97950157 T DK97950157 T DK 97950157T DK 0941221 T3 DK0941221 T3 DK 0941221T3
Authority
DK
Denmark
Prior art keywords
pct
pde inhibitors
substituted dihydrobenzofurans
dihydrobenzofurans
substituted
Prior art date
Application number
DK97950157T
Other languages
English (en)
Inventor
Dieter Flockerzi
Ulrich Thibaut
Armin Hatzelmann
Rolf Beume
Hans-Peter Kley
Dietrich Haefner
Hermann Amschler
Thomas Baer
Beate Schmidt
Hildegard Boss
Thomas Martin
Wolf-Ruediger Ulrich
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0941221T3 publication Critical patent/DK0941221T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97950157T 1996-11-20 1997-11-11 Substituerede dihydrobenzofuraner som PDE-inhibitorer DK0941221T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19647881 1996-11-20
EP96118743 1996-11-22
PCT/EP1997/006248 WO1998022453A1 (en) 1996-11-20 1997-11-11 Substituted dihydrobenzofurans as pde inhibitors

Publications (1)

Publication Number Publication Date
DK0941221T3 true DK0941221T3 (da) 2003-06-10

Family

ID=26031440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97950157T DK0941221T3 (da) 1996-11-20 1997-11-11 Substituerede dihydrobenzofuraner som PDE-inhibitorer

Country Status (12)

Country Link
US (1) US6054475A (da)
EP (1) EP0941221B1 (da)
JP (1) JP2001505198A (da)
AT (1) ATE233252T1 (da)
AU (1) AU5320698A (da)
CY (1) CY2472B1 (da)
DE (1) DE69719358T2 (da)
DK (1) DK0941221T3 (da)
ES (1) ES2193414T3 (da)
PT (1) PT941221E (da)
SI (1) SI0941221T1 (da)
WO (1) WO1998022453A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021558A2 (en) * 1997-10-28 1999-05-06 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
ATE320800T1 (de) 1999-08-21 2006-04-15 Altana Pharma Ag Synergistische kombination von roflumilast und salmeterol
KR20030007575A (ko) * 2000-05-03 2003-01-23 수캄포 아게 안압 강하제
SE0004780D0 (sv) * 2000-12-22 2000-12-22 Jordanian Pharmaceutical Mfg & Novel compunds
JP3940290B2 (ja) * 2000-12-22 2007-07-04 ザ・ヨルダニアン・フアーマシユーテイカル・エム・エフ・ジー・アンド・メデイカル・イクイツプメント・カンパニー・リミテツド 新規化合物
DE60208630T2 (de) * 2001-05-11 2006-08-17 Pfizer Products Inc., Groton Thiazolderivate und ihre Verwendung als cdk-Inhibitoren
IL162602A0 (en) 2001-12-20 2005-11-20 Applied Research Systems Pyrrolidine derivatives as prostaglandin modulators
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
DE10348022A1 (de) * 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677776B2 (en) * 1992-04-02 1997-05-08 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US6121274A (en) * 1994-07-22 2000-09-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Dihydrobenzofurane
DE59610031D1 (de) * 1995-05-18 2003-02-06 Altana Pharma Ag Cyclohexyldihydrobenzofurane
DK0828728T3 (da) * 1995-05-18 2003-05-19 Altana Pharma Ag Phenyldihydrobenzofuraner

Also Published As

Publication number Publication date
EP0941221A1 (en) 1999-09-15
CY2472B1 (en) 2005-06-03
JP2001505198A (ja) 2001-04-17
EP0941221B1 (en) 2003-02-26
AU5320698A (en) 1998-06-10
US6054475A (en) 2000-04-25
ATE233252T1 (de) 2003-03-15
SI0941221T1 (en) 2003-10-31
PT941221E (pt) 2003-07-31
ES2193414T3 (es) 2003-11-01
DE69719358T2 (de) 2003-12-24
WO1998022453A1 (en) 1998-05-28
DE69719358D1 (de) 2003-04-03

Similar Documents

Publication Publication Date Title
DK0941221T3 (da) Substituerede dihydrobenzofuraner som PDE-inhibitorer
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
DK0544819T3 (da) Indolderivater, som inhiberer leukotrienbiosyntese
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
TR200001452T2 (tr) Bifenilamidin türevleri.
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
ATE219481T1 (de) 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivative
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
DE60110124D1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
ATE374189T1 (de) Phthalazinon-derivate als pde 4 hemmer
PT1003724E (pt) Derivados substituidos com accao antiviral
MX9900914A (da)
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
DK0937075T3 (da) Hidtil ukendte imidazo- og oxazolopyridiner som phosphodiesteraseinhibitorer
ECSP982785A (es) Nuevos compuestos de tetrahidroizoquinoleinil- carboxamida, de formula (i) y procedimiento para su obtencion
PT914129E (pt) Utilizacao de aspirocloro ou derivados seus como agentes imunossupresivos